Cyberonics gets Canadian approval for implantable vagus nerve stimulation device:
This article was originally published in Clinica
Executive Summary
Cyberonics has received approval from the Canadian Health protection Branch to market its NeuroCybernetic prosthesis, an implantable device which controls epilepsy by stimulating the vagus nerve. Cyberonics, based in Webster, Texas, estimates that more than 600,000 epileptics worldwide who do not respond to conventional drug therapy or surgery could benefit from the prosthesis.